113 related articles for article (PubMed ID: 9478280)
21. Animal models of breast cancer: experimental design and their use in nutrition and psychosocial research.
Clarke R
Breast Cancer Res Treat; 1997; 46(2-3):117-33. PubMed ID: 9478268
[TBL] [Abstract][Full Text] [Related]
22. A near infrared-modulated thermosensitive hydrogel for stabilization of indocyanine green and combinatorial anticancer phototherapy.
Liu C; Ruan C; Shi R; Jiang BP; Ji S; Shen XC
Biomater Sci; 2019 Mar; 7(4):1705-1715. PubMed ID: 30758351
[TBL] [Abstract][Full Text] [Related]
23. [Correlation between antitumor effects against human mammary carcinoma (MX-1) in nude mice and clinical efficacy of human breast cancer in thirty-four antitumor agents].
Inoue K; Fujimoto S; Ogawa M
Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):13-20. PubMed ID: 6864045
[No Abstract] [Full Text] [Related]
24. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
Elsayed HE; Ebrahim HY; Haggag EG; Kamal AM; El Sayed KA
Bioorg Med Chem; 2017 Dec; 25(24):6297-6312. PubMed ID: 29066046
[TBL] [Abstract][Full Text] [Related]
25. Shikonin induces an anti‑tumor effect on murine mammary cancer via p38‑dependent apoptosis.
Xu J; Koizumi K; Liu M; Mizuno Y; Suzaki M; Iitsuka H; Inujima A; Fujimoto M; Shibahara N; Shimada Y
Oncol Rep; 2019 Mar; 41(3):2020-2026. PubMed ID: 30664166
[TBL] [Abstract][Full Text] [Related]
26. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
[TBL] [Abstract][Full Text] [Related]
27. Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.
Li J; Yao QY; Xue JS; Wang LJ; Yuan Y; Tian XY; Su H; Wang SY; Chen WJ; Lu W; Zhou TY
Acta Pharmacol Sin; 2017 Sep; 38(9):1282-1296. PubMed ID: 28649130
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer.
Norton L
Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263
[TBL] [Abstract][Full Text] [Related]
29. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
30. [Genistein: a soy isoflavone revealing a pleiotropic mechanism of action - clinical implications in the treatment and prevention of cancer].
Radzikowski C; Wietrzyk J; Grynkiewicz G; Opolski A
Postepy Hig Med Dosw (Online); 2004 Feb; 58():128-39. PubMed ID: 15077059
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human erythropoietin in combination with chemotherapy increases breast cancer metastasis in preclinical mouse models.
Hedley BD; Chu JE; Ormond DG; Beausoleil MS; Boasie A; Allan AL; Xenocostas A
Clin Cancer Res; 2011 Oct; 17(19):6151-62. PubMed ID: 21856770
[TBL] [Abstract][Full Text] [Related]
32. Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis.
Arya RK; Singh A; Yadav NK; Cheruvu SH; Hossain Z; Meena S; Maheshwari S; Singh AK; Shahab U; Sharma C; Singh K; Narender T; Mitra K; Arya KR; Singh RK; Gayen JR; Datta D
Sci Rep; 2015 Dec; 5():18457. PubMed ID: 26672742
[TBL] [Abstract][Full Text] [Related]
33. De Novo Design of Phototheranostic Sensitizers Based on Structure-Inherent Targeting for Enhanced Cancer Ablation.
Li M; Long S; Kang Y; Guo L; Wang J; Fan J; Du J; Peng X
J Am Chem Soc; 2018 Nov; 140(46):15820-15826. PubMed ID: 30380856
[TBL] [Abstract][Full Text] [Related]
34. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
35. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
36. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP
Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models.
Badr G; Al-Sadoon MK; Rabah DM
Free Radic Biol Med; 2013 Dec; 65():175-189. PubMed ID: 23811005
[TBL] [Abstract][Full Text] [Related]
38. Progesterone antagonists: tumor-inhibiting potential and mechanism of action.
Michna H; Nishino Y; Neef G; McGuire WL; Schneider MR
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):339-48. PubMed ID: 1562510
[TBL] [Abstract][Full Text] [Related]
39. Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism.
Ketchart W; Yeh IJ; Zhou H; Thiagarajan PS; Lathia J; Reizes O; Exner A; Su B; Montano MM
Cancer Lett; 2016 Aug; 379(1):60-9. PubMed ID: 27238569
[TBL] [Abstract][Full Text] [Related]
40. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
